efavirenz and Neoplasms

efavirenz has been researched along with Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Feng, JH; Inci, G; Jung, JS; Kang, BG; Kim, JH; Kim, SB; Kim, SC; Lee, JY; Lim, SS; Mo, YW; Park, SH; Seo, JH; Shende, M; Suh, HW1
Nordling, L1
Beumer, JH; Christner, SM; Gramignoli, R; Parise, RA; Pillai, VC; Rudek, MA; Strom, SC; Venkataramanan, R1

Other Studies

3 other study(ies) available for efavirenz and Neoplasms

ArticleYear
Combination of metformin/efavirenz/fluoxetine exhibits profound anticancer activity via a cancer cell-specific ROS amplification.
    Cancer biology & therapy, 2023, 12-31, Volume: 24, Issue:1

    Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Cell Line, Tumor; Fluoxetine; HCT116 Cells; Humans; Metformin; Mice; Mice, Nude; Neoplasms; Reactive Oxygen Species; Signal Transduction

2023
How the genomics revolution could finally help Africa.
    Nature, 2017, 04-05, Volume: 544, Issue:7648

    Topics: Africa; Alkynes; Anti-HIV Agents; Apolipoprotein L1; Apolipoproteins; Benzoxazines; Black People; Charities; Cyclopropanes; Diabetes Mellitus, Type 2; Genetic Predisposition to Disease; Genetics, Medical; Genome-Wide Association Study; Genomics; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Kidney Diseases; Lipoproteins, HDL; National Institutes of Health (U.S.); Neoplasms; Oxazines; Piperazines; Polymorphism, Single Nucleotide; Precision Medicine; Public Health; Pyridones; Reverse Transcriptase Inhibitors; Stroke; Trypanosomiasis, African; United States; White People

2017
Ritonavir and efavirenz significantly alter the metabolism of erlotinib--an observation in primary cultures of human hepatocytes that is relevant to HIV patients with cancer.
    Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:10

    Topics: 14-alpha Demethylase Inhibitors; Adult; Aged; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Interactions; Erlotinib Hydrochloride; Female; Half-Life; Hepatocytes; HIV Infections; HIV Protease Inhibitors; Humans; Ketoconazole; Male; Middle Aged; Neoplasms; Nucleic Acid Synthesis Inhibitors; Quinazolines; Rifampin; Ritonavir

2013